Medicamen Biotech Limited — Board Meeting, 12-08-2025: Outcome of Board Meeting

Medicamen Biotech's board has approved its consolidated financial results for the quarter ended June 30, 2025. The company also announced a potential final dividend of Re. 1 per equity share (10%) for FY24-25, subject to shareholder approval at the upcoming 32nd Annual General Meeting. The AGM is scheduled virtually for September 26, 2025. Additionally, the board appointed Mr. Ashwani Kumar Sharma as Executive Director for five years and welcomed Mr. Sham Goel and Mr. Shaival Saurabh as new Non-Executive Independent Directors, further strengthening its leadership team.